OOIR: Observatory of International Research

Papers

(The median citation count of Clinical and Translational Allergy is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Is diet partly responsible for differences in COVID-19 death rates between and within countries?	90
Non‐specific lipid‐transfer proteins: Allergen structure and function, cross‐reactivity, sensitization, and epidemiology	67
Male sex is strongly associated with IgE-sensitization to airborne but not food allergens: results up to age 24 years from the BAMSE birth cohort	52
Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies	50
Worldwide prevalence of rhinitis in adults: A review of definitions and temporal evolution	50
Distinct type 2-high inflammation associated molecular signatures of chronic rhinosinusitis with nasal polyps with comorbid asthma	38
AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer—a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI)	37
IgE autoantibodies and autoreactive T cells and their role in children and adults with atopic dermatitis	34
Initiating pollen sensitization – complex source, complex mechanisms	33
Molecular approach to a patient’s tailored diagnosis of the oral allergy syndrome	32
Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study	30
Fungal and bacterial microbiome dysbiosis and imbalance of trans-kingdom network in asthma	30
Patients with suspected allergic reactions to COVID‐19 vaccines can be safely revaccinated after diagnostic work‐up	30
Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK‐air®	29
Respiratory diseases and allergy in farmers working with livestock: a EAACI position paper	29
The applications of eHealth technologies in the management of asthma and allergic diseases	27
Anaphylactic risk related to omalizumab, benralizumab, reslizumab, mepolizumab, and dupilumab	27
Allergy to polyethylene glycol and polysorbates in a patient cohort: Diagnostic work‐up and decision points for vaccination during the COVID‐19 pandemic	26
Genomics of asthma, allergy and chronic rhinosinusitis: novel concepts and relevance in airway mucosa	26
Role of IL‐17 in atopy—A systematic review	24
ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy	23
Epinephrine delivery via EpiPen® Auto-Injector or manual syringe across participants with a wide range of skin-to-muscle distances	23
Long‐term safety and effectiveness of berotralstat for hereditary angioedema: The open‐label APeX‐S study	22
The role of antifungals in the management of patients with severe asthma	21
Involvement of the extracellular matrix proteins periostin and tenascin C in nasal polyp remodeling by regulating the expression of MMPs	21

Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model	20
Citrullinated histone H3, a marker of extracellular trap formation, is increased in blood of stable asthma patients	20
Comorbidities in hereditary angioedema—A population‐based cohort study	20
The need for Pan‐European automatic pollen and fungal spore monitoring: A stakeholder workshop position paper	19
Chemokines during anaphylaxis: the importance of CCL2 and CCL2-dependent chemotactic activity for basophils	19
Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis	18
COST Action ‘ImpARAS’: what have we learnt to improve food allergy risk assessment. A summary of a 4 year networking consortium	18
A novel histopathological scoring system to distinguish urticarial vasculitis from chronic spontaneous urticaria	18
Secretory protein beta‐lactoglobulin in cattle stable dust may contribute to the allergy‐protective farm effect	18
Current transition management of adolescents and young adults with allergy and asthma: a European survey	17
Real‐life effectiveness of biological therapies on symptoms in severe asthma with comorbid CRSwNP	16
Psychological needs and support among patients and families undergoing food oral immunotherapy	16
Frequency of severe reactions following penicillin drug provocation tests: A Bayesian meta‐analysis	16
Digital transformation of health and care to sustain Planetary Health: The MASK proof-of-concept for airway diseases—POLLAR symposium under the auspices of Finland’s Presidency of the EU, 2019 and MAC	15
Drug-related relapses in drug reaction with eosinophilia and systemic symptoms (DRESS)	15
Development of childhood asthma prediction models using machine learning approaches	15
DNA methylation biomarkers in asthma and rhinitis: Are we there yet?	14
Topical inflammasome inhibition with disulfiram prevents irritant contact dermatitis	14
Viral infections and wheezing–asthma inception in childhood: is there a role for immunomodulation by oral bacterial lysates?	14
New approach to intermittent and mild asthma therapy: evolution or revolution in the GINA guidelines?	13
Food protein‐induced enterocolitis syndrome: A large French multicentric experience	13
En route to personalized medicine: uncovering distinct IgE reactivity pattern to house dust mite components in Brazilian and Austrian allergic patients	13
Eustachian tube dysfunction in patients with house dust mite-allergic rhinitis	13
Epigenome-wide association study identifies DNA methylation markers for asthma remission in whole blood and nasal epithelium	12
The basophil activation test differentiates between patients with wheat‐dependent exercise‐induced anaphylaxis and control subjects using gluten and isolated gluten protein types	12
Anomalous asthma and chronic obstructive pulmonary disease Google Trends patterns during the COVID-19 pandemic	12
Increasing incidence of anaphylaxis in Hong Kong from 2009 to 2019—discrepancies of anaphylaxis care between adult and paediatric patients	12
EAACI anaphylaxis guidelines: systematic review protocol	12
Allergic patients during the COVID‐19 pandemic—Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey	12
Allergen exposure chambers: implementation in clinical trials in allergen immunotherapy	12
Primary eosinophilic gastrointestinal disorders and allergy: Clinical and therapeutic implications	12
Direct and indirect costs of allergic and non‐allergic rhinitis to adults in Beijing, China	12
The disease burden in patients with respiratory allergies induced by house dust mites: a year-long observational survey in three European countries	11
Omalizumab for successful chemotherapy desensitisation: What we know so far	11
Real‐world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities	11
EAACI Task force Clinical epidemiology of anaphylaxis: experts’ perspective on the use of adrenaline autoinjectors in Europe	11
Leptin favors Th17/Treg cell subsets imbalance associated with allergic asthma severity	11
Environmental and sensitization variations among asthma and/or rhinitis patients between 2008 and 2018 in China	11
Gram‐negative microbiota is related to acute exacerbation in children with asthma	11
Efficacy and safety of intralymphatic immunotherapy in allergic rhinitis: A systematic review and meta‐analysis	11
Large‐scale plasma proteomics can reveal distinct endotypes in chronic obstructive pulmonary disease and severe asthma	11
Efficacy, safety, and tolerability of lebrikizumab in adolescent patients with uncontrolled asthma (ACOUSTICS)	10
Penicillin and cephalosporin cross-reactivity: role of side chain and synthetic cefadroxil epitopes	10
Clinical and inflammatory characteristics of patients with asthma in the Spanish MEGA project cohort	10
Immunoregulatory effects of Lactococcus lactis‐derived extracellular vesicles in allergic asthma	10
IL‐19 induced by IL‐13/IL‐17A in the nasal epithelium of patients with chronic rhinosinusitis upregulates MMP‐9 expression via ERK/NF‐κB signaling pathway	10
Variation in IgE binding potencies of seven Artemisia species depending on content of major allergens	10
Apple allergy: Causes and factors influencing fruits allergenic properties–Review	10
Omalizumab is effective in the preseasonal treatment of seasonal allergic rhinitis	10
Mastocytosis presenting with mast cell‐mediator release‐associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory features	10

Allergen immunotherapy for respiratory allergy: Quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool. An EAACI methodology committee analys	9
Predictive significance of Charcot‐Leyden crystal structures for nasal polyp recurrence	9
A meta‐analysis on allergen‐specific immunotherapy using MCT^® (MicroCrystalline Tyrosine)‐adsorbed allergoids in pollen allergic patients suffering from allergic rhinoconjunctivitis	9
Integration of in vitro allergy test results and ratio analysis for the diagnosis and treatment of allergic patients (INTEGRA)	9
Impact on quality of life and safety of sublingual and subcutaneous immunotherapy in children with severe house dust mite and pollen-associated allergic rhinoconjunctivitis	9
IgE-binding to vicilin-like antimicrobial peptides is associated with systemic reactions to macadamia nut	9
Chronic urticaria patients are interested in apps to monitor their disease activity and control: A UCARE CURICT analysis	9
Unravelling the expression of interleukin-9 in chronic rhinosinusitis: A possible role for Staphylococcus aureus	9
IgE and high‐affinity IgE receptor in chronic inducible urticaria, pathogenic, and management relevance	8
Characteristics, mechanism, and management of pain in atopic dermatitis: A literature review	8
Effects of ectoine containing nasal spray and eye drops on symptoms of seasonal allergic rhinoconjunctivitis	8
Birch allergen challenges in allergic conjunctivitis using standard conjunctival allergen challenge and environmental exposure chamber	8
Ligelizumab improves sleep interference and disease burden in patients with chronic spontaneous urticaria	8
Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries?	8
Mobile health app for monitoring allergic rhinitis and asthma in real life in Lithuanian MASK‐air users	8
Heterogeneous validity of daily data on symptoms of seasonal allergic rhinitis recorded by patients using the e‐diary AllergyMonitor®	8
Total IgE in tears accurately reflects the severity and predicts the prognosis of seasonal allergic conjunctivitis	8
Association of asthma genetic variants with asthma‐associated traits reveals molecular pathways of eosinophilic asthma	8
Effects of early‐life exposure to dust mite allergen and endotoxin on the development of asthma and wheezing: The Japan Environment and Children's Study	8
Allergen Immunotherapy (AIT) in children: a vulnerable population with its own rights and legislation – summary of EMA-initiated multi-stakeholder meeting on Allergen Immunotherapy (AIT) for children,	8
Clinical trials in allergen immunotherapy in the age group of children and adolescents: current concepts and future needs	8
Protocol of safe vaccination against COVID‐19 in patients with high risk of allergic reactions	8
Prospective Italian real‐world study of mepolizumab in severe eosinophilic asthma validates retrospective outcome reports	7
Systematic review of monotherapy with biologicals for children and adults with IgE‐mediated food allergy	7
Cross‐reactivity between tick and wasp venom can contribute to frequent wasp sensitization in patients with the α‐Gal syndrome	7
Combinations of self‐reported rhinitis, conjunctivitis, and asthma predicts IgE sensitization in more than 25,000 Danes	7
Contact allergens in moisturizers in preventative emollient therapy – A systematic review	7
Control of Allergic Rhinitis and Asthma Test: A systematic review of measurement properties and COSMIN analysis	7
The health economic impact of cow's milk allergy in childhood: A retrospective cohort study	7
Predictors of asthma‐related quality of life in a large cohort of asthmatics: A cross‐sectional study in a secondary care center	7
Pru du 1, the Bet v 1‐homologue from almond, is a major allergen in patients with birch pollen associated almond allergy	7
Incidence of anaphylaxis and accidental peanut exposure: A systematic review	7
Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air^®approach	7
Reduced exacerbation frequency and prednisone dose in patients with ABPA and asthma treated with dupilumab	7
Allergen immunotherapy in MASK‐air users in real‐life: Results of a Bayesian mixed‐effects model	7
AllergoOncology: Role of immune cells and immune proteins	6
Prenatal PM_2.5 affects atopic dermatitis depending on maternal anxiety and gender: COCOA study	6
Home‐based graded exposure to egg to treat egg allergy	6
Correction to: Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper	6
Persistent human bocavirus 1 infection and tonsillar immune responses	6
Efficacy and safety of oral immunotherapy for peanut, cow's milk, and hen's egg allergy: A systematic review of randomized controlled trials	6
Preference for sublingual immunotherapy with tablets in a Spanish population with allergic rhinitis	6
Adverse events for biologics in patients with CRSwNP: A meta‐analysis	6
Reviewing clinical considerations and guideline recommendations of C1 inhibitor prophylaxis for hereditary angioedema	6
Chronic rhinosinusitis with and without nasal polyps and asthma: Omalizumab improves residual anxiety but not depression	6
Effect of air filtration on house dust mite, cat and dog allergens and particulate matter in homes	6
Circulating miRNAs—A potential tool to identify severe asthma risk?	6
Recent advances and developments in COVID‐19 in the context of allergic diseases	6
Heterogeneity of magnitude, allergen immunodominance, and cytokine polarization of cockroach allergen‐specific T cell responses in allergic sensitized children	6
Sensitization against skin resident fungi is associated with atopy in cholinergic urticaria patients	6
Children and caregiver proxy quality of life from peanut oral immunotherapy trials	6
Clinical review: The suggested management pathway for urticaria in primary care	6
Course of IgE to α‐Gal in a Swedish population of α‐Gal syndrome patients	6
Pru p 3 oral immunotherapy efficacy, induced immunological changes and quality of life improvement in patients with LTP syndrome	5
The value of small airway function parameters and fractional exhaled nitric oxide for predicting positive methacholine challenge test in asthmatics of different ages with FEV₁ ≥ 80% predict	5
Genetic variants in Hippo pathway genes are associated with house dust mite‐induced allergic rhinitis in a Chinese population	5
Altered innate immune profile in blood of systemic mastocytosis patients	5
Causal risk factors for asthma in Mendelian randomization studies: A systematic review and meta‐analysis	5
Budesonide repairs decreased barrier integrity of eosinophilic nasal polyp epithelial cells caused by PM_2.5	5
Transcriptome sequencing reveals altered ciliogenesis under hypoxia in nasal epithelial cells from chronic rhinosinusitis with nasal polyps	5
The influence of individual characteristics and non‐respiratory diseases on blood eosinophil count	5
Comparative short‐term efficacy of endoscopic sinus surgery and biological therapies in chronic rhinosinusitis with nasal polyps: A network meta‐analysis	5
Remibrutinib inhibits hives effector cells stimulated by serum from chronic urticaria patients independently of FcεR1 expression level and omalizumab clinical response	5
Highlights and recent developments in allergic diseases in EAACI journals (2019)	5
Relationship between longitudinal changes in type‐2 inflammation, immunoglobulin E sensitization, and clinical outcomes in young asthmatics	5
Dynamic trends in skin barrier function from birth to age 6 months and infantile atopic dermatitis: A Chinese prospective cohort study	5
Mastocytosis patients' cognitive dysfunctions correlate with the presence of spindle‐shaped mast cells in bone marrow	5
The SP‐TLR axis, which locally primes the nasal mucosa, is impeded in patients with allergic rhinitis	5
Primary non-adherence to inhaled medications measured with e-prescription data from Poland	5
Effectiveness of mobile health interventions to improve nasal corticosteroid adherence in allergic rhinitis: A systematic review	5
The association between airborne pollen monitoring and sensitization in the hot desert climate	5
Systemic and local evidence for complement involvement in chronic spontaneous urticaria	5
Symptom control and health‐related quality of life in allergic rhinitis with and without comorbid asthma: A multicentre European study	5
Obese asthma phenotypes display distinct plasma biomarker profiles	5
Allergy screening with extract‐based skin prick tests demonstrates higher sensitivity over in vitro molecular allergy testing	5
The characteristics of upper airway edema in hereditary and acquired angioedema with C1‐inhibitor deficiency	5
Subcutaneous birch pollen allergen immunotherapy with a depigmented polymerized extract shows only sustained and long‐term efficacy in a subgroup of monosensitized adults and adolescents with allergic	5
Worldwide surveys on anaphylaxis to sublingual immunotherapy with house dust mite tablets are urgently needed	5
The association of asthma, atopic dermatitis, and allergic rhinitis with peripartum mental disorders	4
Effectiveness of mepolizumab in severe asthma in Japan: A real‐world study using claims data	4

Available and affordable complementary treatments for COVID‐19: From hypothesis to pilot studies and the need for implementation	4
Effects of anti‐IL5 biological treatments on blood IgE levels in severe asthmatic patients: A real‐life multicentre study (BIONIGE)	4
Sensitivity to change and minimal clinically important difference of the angioedema control test	4
Fractional exhaled nitric oxide levels in relation to work‐related respiratory burden and sensitization to wheat flour and multigrain in bakers	4
Allergy‐related diseases and early gut fungal and bacterial microbiota abundances in children	4
Dietary fibre in relation to asthma, allergic rhinitis and sensitization from childhood up to adulthood	4
Does treatment with antidepressants, antipsychotics, or benzodiazepines hamper allergy skin testing?	4
High dupilumab levels in tear fluid of atopic dermatitis patients with moderate‐to‐severe ocular surface disease	4
Hereditary angioedema caused by a premature stop codon mutation in the SERPING1 gene	4
Allergic sensitization to lipocalins reflects asthma morbidity in dog dander sensitized children	4
The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis	4
Allergen immunotherapy during the COVID‐19 pandemic—A survey of the German Society for Allergy and Clinical Immunology	4
Reducing severe cutaneous adverse and type B adverse drug reactions using pre‐stored human leukocyte antigen genotypes	4
Comparative metabolomics analysis of bronchial epithelium during barrier establishment after allergen exposure	4
Beliefs about food allergies in adolescents aged 11–19 years: A systematic review	4
Current pet ownership modifies the adverse association between long‐term ambient air pollution exposure and childhood asthma	4
Efficacy of probiotics in pediatric atopic dermatitis: A systematic review and meta‐analysis	4
Understanding and controlling asthma in Latin America: A review of recent research informed by the SCAALA programme	4
EczemaPred: A computational framework for personalised prediction of eczema severity dynamics	4
Biomarkers for predicting response to long‐term high dose aspirin therapy in aspirin‐exacerbated respiratory disease	4
Enhanced expression of endogenous retroviruses and of TRIM28 and SETDB1 in children with food allergy	4
Cow's milk and hen's egg anaphylaxis: A comprehensive data analysis from the European Anaphylaxis Registry	3
Detection of clonal mast cell disease in wasp venom allergic patients with normal tryptase	3
A scoping review: What are the cellular mechanisms that drive the allergic inflammatory response to fungal allergens in the lung epithelium?	3
Normalisation of airflow limitation in asthma: Post‐hoc analyses of TRIMARAN and TRIGGER	3
A novel ELISA method to determine human MrgX2 in chronic urticaria	3
Peanut allergy: Beyond the oral immunotherapy plateau	3
Data‐driven research on eczema: Systematic characterization of the field and recommendations for the future	3
Recent patents in allergy and immunology: A quantitative real‐time polymerase chain reaction method for diagnosing asthma and asthma exacerbation	3
Comparative study of novel dosing schedules for interrupted immunotherapy for allergic rhinitis	3
Validation of diagnostic and predictive biomarkers for hereditary angioedema via plasma N‐glycomics	3
Developing integrated care pathways for atopic dermatitis—Challenges and unmet needs	3
Predicting Blomia tropicalis allergens using a multiomics approach	3
Non‐eosinophilic asthma in nonsteroidal anti‐inflammatory drug exacerbated respiratory disease	3
Primary care as a setting for introducing milk using the milk ladder in children with IgE‐mediated cow's milk protein allergy	3
The holo beta‐lactoglobulin lozenge reduces symptoms in cat allergy—Evaluation in an allergen exposure chamber and by titrated nasal allergen challenge	3
The relative proportion of comorbidities among rhinitis and rhinosinusitis patients and their impact on visit burden	3
The burden of chronic rhinosinusitis with nasal polyps and its relation to asthma in Finland	3
Characterization, epidemiology and risk factors of multiple drug allergy syndrome and multiple drug intolerance syndrome: A systematic review	3
Prevalence, predictors, and clinical relevance of α‐gal sensitization in patients with chronic urticaria	3
The SQ HDM SLIT‐Tablet is safe and well tolerated in patients with House Dust Mite allergic rhinitis with or without asthma: A “real‐life” French study	3
MiR‐29b regulates Th2 cell differentiation in asthma by targeting inducible B7‐H3 and STAT3	3
Persistence in allergen immunotherapy: A longitudinal, prescription data‐based real‐world analysis	3
Peach allergen Pru p 1 content is generally low in fruit but with large variation in different varieties	3
Molecular allergy diagnosis is sensitive and avoids misdiagnosis in patients sensitized to seasonal allergens	2
New insights into the regulation of TGF‐β/Smad and MPK signaling pathway gene expressions by nasal allergen and methacholine challenge test in asthma	2
HLA‐A24:02 increase the risk of allopurinol‐induced drug reaction with eosinophilia and systemic symptoms in HLA‐B58:01 carriers in a Korean population; a multicenter cross‐sectional case‐control st	2
High‐dose non‐sedating antihistamines are used insufficiently in chronic urticaria patients treated with omalizumab	2
Management of patients with seasonal allergic rhinitis: Diagnostic consideration of sensitization to non‐frequent pollen allergens	2
Omalizumab prevents respiratory illnesses in non‐atopic chronic spontaneous urticaria patients: A prospective, parallel‐group, pilot pragmatic trial	2
Low dietary adherence after a positive food challenge in food allergic adults	2
Management of allergic rhinitis symptoms in the pharmacy Pocket guide 2022	2
Complex IgE sensitization patterns in ragweed allergic patients: Implications for diagnosis and specific immunotherapy	2
Impact of environmental factors in predicting daily severity scores of atopic dermatitis	2
Retraction Note to: Partially hydrolysed, prebiotic supplemented whey formula for the prevention of allergic manifestations in high risk infants: a multicentre double-blind randomised controlled trial	2
DNA methylation profile in patients with indolent systemic mastocytosis	2
How reliably can algorithms identify eosinophilic asthma phenotypes using non‐invasive biomarkers?	2
Lung miRNA profiles show a time‐of‐day response in house dust mite‐induced allergic asthma in mice	2
Pharmacokinetic equivalence of CT‐P39 and reference omalizumab in healthy individuals: A randomised, double‐blind, parallel‐group, Phase 1 trial	2
The use of patient‐reported outcome measures by healthcare professionals in specialized asthma management centers in French‐speaking Belgium: A mixed‐methods study	2
Artificial intelligence processing electronic health records to identify commonalities and comorbidities cluster at Immuno Center Humanitas	2
Different effects of smoking on atopic and non‐atopic adult‐onset asthma	2
Current challenges and future opportunities in patient‐focused management of hereditary angioedema: A narrative review	2
Reactivity to allergenic food contaminants: A study on products on the market	2
School allergy training promotes internal policy review and enhances staff's preparedness in managing pupils with food allergy	2
Prevalence of sensitization to molecular food allergens in Europe: A systematic review	2